Report #2850103

Received Jul 17, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 56 yrs
State: MA
Recovered: Recovered
Vaccinated: Jul 8, 2025
Onset: Jul 11, 2025
Days to onset: 3
Hospital days: —

Vaccines (3)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HEP	HEP B (HEPLISAV-B)	DYNAVAX TECHNOLOGIES CORPORATION	2	946064	IM / LA
PNC20	PNEUMO (PREVNAR20)	PFIZER\WYETH	1	MF0425	IM / LA
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	1	2HJ99	IM / RA

Symptoms (4)

Injection site painInjection site rashInjection site warmthRash erythematous

Symptom narrative

erythematous rash on left shoulder near the injection site, 10x10 cm ~ well demarcated with raised boarders, tender and warm. Treatment: Local reactions can be treated with tylenol or nonsteroidal antiinflammatory drugs (NSAIDs) such as naproxen as needed if pain or swelling is troublesome. -Cetirizine 10 mg nightly x7, can stop earlier if symptoms resolve -Due to complains of a reactive cough and worsening local erythema, prednisone 20 mg for 5 days was also sent.

Current illness

none

Medical history

seasonal allergies

Other medications

Lexapro, Albuterol, Vitamin D-3

Allergies

morphine, Oxycodone, Oxycodone-acetaminophen

Lab data

none